Gilead Sciences

About:

Gilead Sciences is a biopharmaceutical company that discovers, develops, manufactures and commercializes therapies for critical diseases.

Website: http://www.gilead.com

Twitter/X: GileadSciences

Top Investors: Abingworth, Venrock

Description:

Gilead Sciences is a research-based biopharmaceutical company that discovers, develops, and commercializes innovative medicines in areas of unmet need. With each new discovery and experimental drug candidate, they seek to improve the care of patients suffering from life-threatening diseases. Gilead's primary areas of focus include HIV/AIDS, liver disease, and serious cardiovascular and respiratory conditions.

Total Funding Amount:

$4.41B

Estimated Revenue Range:

$10B+

Headquarters Location:

Foster City, California, United States

Founded Date:

1987-06-22

Contact Email:

public_affairs(AT)gilead.com

Founders:

Michael L. Riordan

Number of Employees:

10001+

Last Funding Date:

2024-11-13

IPO Status:

Public

© 2025 bioDAO.ai